Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
TCM Ltd (TCMLMTD) is currently trading at 45.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
TCM Limited engages in solar panel trading and healthcare product manufacturing alongside solar panel installation and cattle feed production. Originally a chemical manufacturing company, TCM faced financial struggles leading to a shift in business focus. In 2023, TCM updated its Memorandum of Association to include township development and infrastructure projects, showcasing diversification efforts. TCM has recently established subsidiaries focusing on healthcare, property development, and solar projects, indicating a strategic shift towards new verticals. Despite past financial challenges, the company is actively reviving operations with new business activities aligned with market opportunities.
Over the past 52 weeks, TCM Ltd has traded between a low of ₹36.53 and a high of ₹81.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
TCM Ltd has a market capitalization of approximately 33.64. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
TCM Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -5.79 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 33.64 Cr, TCM Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
TCM Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of TCM Ltd is -5.79. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
6
Neutral
4
Bullish
4
Bearish
19
Neutral
4
Bullish
23
Bearish
13
Neutral
0
Bullish
19
TCM Limited engages in solar panel trading and healthcare product manufacturing alongside solar panel installation and cattle feed production. Originally a chemical manufacturing company, TCM faced financial struggles leading to a shift in business focus.
In 2023, TCM updated its Memorandum of Association to include township development and infrastructure projects, showcasing diversification efforts.
TCM has recently established subsidiaries focusing on healthcare, property development, and solar projects, indicating a strategic shift towards new verticals.
Despite past financial challenges, the company is actively reviving operations with new business activities aligned with market opportunities.
Chemicals & Petrochemicals
Commodity Chemicals
34 Cr
High Risk
-5.8
42.5
—
1.4
81.00
36.53
Sales CAGR
Profit CAGR
ROE
ROCE
Board Meeting
TCM Ltd will hold a Board meeting on 2026-08-13 at 10:30 to consider and approve consolidated and standalone unaudited financial results for Q1 ended 30 Jun 2026, approve Directors' Report, fix 82nd AGM date; trading window note.
Board Meeting
TCM Ltd notifies board meeting on 2026-08-13 at 10:30 AM to consider and approve consolidated and standalone unaudited financial results for quarter ended 30 June 2026, approve directors' report, fix AGM date and related matters.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
51.78 | 43 Cr | 12.85 | 1.31 | 0.00 | 10.20 | 8.66 | 2.55 | ||
45.00 | 34 Cr | -5.79 | 1.36 | 0.00 | -23.53 | -8.66 | -7.26 | ||
41.43 | 32 Cr | -1599.50 | 0.87 | 0.00 | 2.84 | 3.00 | -0.52 | ||
64.40 | 32 Cr | 16.81 | 0.71 | 0.00 | 5.30 | 8.02 | 3.61 | ||
47.23 | 29 Cr | 20.74 | 2.77 | 0.00 | 14.62 | 10.75 | 2.81 | ||
48.02 | 28 Cr | -157.22 | 49.38 | 0.00 | -34.59 | -2.22 | -2.14 | ||
6.15 | 27 Cr | -342.38 | 1.95 | 0.00 | 2.63 | 2.86 | -0.37 | ||
| Median: 7 Co. | — | 47.23 | 32 Cr | -5.79 | 1.36 | 0.00 | 2.84 | 3.00 | -0.37 |
